MDM2 and cancer: Therefore, we proposed that plasma-induced oxidized Mdm2 does not inhibit p53, which might be the possible reason for catalase deactivation by p53 rather than singlet oxygen generated in plasma-induced reactions, which results in increased intracellular ROS in the plasma-treated cancer cells.